SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey.

COVID-19 ESKD SARS-CoV-2 dialysis vaccine

Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 26 01 2021
accepted: 15 03 2021
pubmed: 1 5 2021
medline: 1 5 2021
entrez: 30 4 2021
Statut: ppublish

Résumé

Patients on dialysis are at increased risk for COVID-19-related complications. However, a substantial fraction of patients on dialysis belong to groups more likely to be hesitant about vaccination. With the goal of identifying strategies to increase COVID-19 vaccine uptake among patients on hemodialysis, we conducted a nationwide vaccine acceptability survey, partnering with a dialysis network to distribute an anonymized English and Spanish language online survey in 150 randomly selected facilities in the United States. We used logistic regression to evaluate characteristics of vaccine-hesitant persons. A total of 1515 (14% of eligible) patients responded; 20% of all responders, 29% of patients aged 18-44 years, and 29% of Black responders reported being hesitant to seek the COVID-19 vaccine, even if the vaccine was considered safe for the general population. Odds of vaccine hesitancy were higher among patients aged 18-44 years versus those 45-64 years (odds ratio [OR], 1.5; 95% confidence interval [95% CI], 1.0 to 2.3), Black patients versus non-Hispanic White patients (OR, 1.9; 95% CI, 1.3 to 2.7), Native Americans or Pacific Islanders versus non-Hispanic White patients (OR, 2.0; 95% CI, 1.1 to 3.7), and women versus men (OR, 1.6; 95% CI, 1.2 to 2.0). About half (53%) of patients who were vaccine hesitant expressed concerns about side effects. Responders' main information sources about COVID-19 vaccines were television news and dialysis staff (68% and 38%, respectively). A substantial proportion of patients receiving in-center hemodialysis in the United States are hesitant about seeking COVID-19 vaccination. Facilitating uptake requires outreach to younger patients, women, and Black, Native American, or Pacific Islander patients, and addressing concerns about side effects. This article contains a podcast at https://www.asn-online.org/media/podcast/JASN/2021_07_07_JASN2021010104.mp3.

Sections du résumé

BACKGROUND BACKGROUND
Patients on dialysis are at increased risk for COVID-19-related complications. However, a substantial fraction of patients on dialysis belong to groups more likely to be hesitant about vaccination.
METHODS METHODS
With the goal of identifying strategies to increase COVID-19 vaccine uptake among patients on hemodialysis, we conducted a nationwide vaccine acceptability survey, partnering with a dialysis network to distribute an anonymized English and Spanish language online survey in 150 randomly selected facilities in the United States. We used logistic regression to evaluate characteristics of vaccine-hesitant persons.
RESULTS RESULTS
A total of 1515 (14% of eligible) patients responded; 20% of all responders, 29% of patients aged 18-44 years, and 29% of Black responders reported being hesitant to seek the COVID-19 vaccine, even if the vaccine was considered safe for the general population. Odds of vaccine hesitancy were higher among patients aged 18-44 years versus those 45-64 years (odds ratio [OR], 1.5; 95% confidence interval [95% CI], 1.0 to 2.3), Black patients versus non-Hispanic White patients (OR, 1.9; 95% CI, 1.3 to 2.7), Native Americans or Pacific Islanders versus non-Hispanic White patients (OR, 2.0; 95% CI, 1.1 to 3.7), and women versus men (OR, 1.6; 95% CI, 1.2 to 2.0). About half (53%) of patients who were vaccine hesitant expressed concerns about side effects. Responders' main information sources about COVID-19 vaccines were television news and dialysis staff (68% and 38%, respectively).
CONCLUSIONS CONCLUSIONS
A substantial proportion of patients receiving in-center hemodialysis in the United States are hesitant about seeking COVID-19 vaccination. Facilitating uptake requires outreach to younger patients, women, and Black, Native American, or Pacific Islander patients, and addressing concerns about side effects.
PODCAST UNASSIGNED
This article contains a podcast at https://www.asn-online.org/media/podcast/JASN/2021_07_07_JASN2021010104.mp3.

Identifiants

pubmed: 33927004
pii: 00001751-202107000-00008
doi: 10.1681/ASN.2021010104
pmc: PMC8425649
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1575-1581

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK127138
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK085466
Pays : United States

Informations de copyright

Copyright © 2021 by the American Society of Nephrology.

Références

Centers for Medicare and Medicaid Services: Preliminary Medicare COVID-19 data snapshot. 2021. Available at: https://www.cms.gov/research-statistics-data-systems/preliminary-medicare-covid-19-data-snapshot . Accessed February 20, 2021
Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, et al.; Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium: Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int 98: 1530–1539, 2020 32810523
Liu CK, Ghai S, Waikar SS, Weiner DE: COVID-19 infection risk among hemodialysis patients in long-term care facilities. Kidney Med 2: 810–811, 2020 33015605
Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM: Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults. Ann Intern Med 173: 964–973, 2020 32886525
Funk C, Tyson A: Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases, 2020. Available at: https://www.pewresearch.org/science/2020/12/03/intent-to-get-a-covid-19-vaccine-rises-to-60-as-confidence-in-research-and-development-process-increases/ . Accessed January 21, 2021
Danziger J, Weinhandl E, Friedman D, Mukamal KJ: Racial and ethnic disparities in seasonal influenza vaccination among dialysis facilities in the United States. J Am Soc Nephrol 31: 2117–2121, 2020 32817310
National Foundation for Infectious Disease: National survey: black adult perspectives on COVID-19 and flu vaccines, 2021. Available at: https://www.nfid.org/national-survey-black-adult-perspectives-on-covid-19-and-flu-vaccines/ . Accessed February 6, 2021
Rossi PH, Wright JD, Anderson AB: Handbook of Survey Research, Cambridge, Massachusetts, Academic Press, 2013
Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, et al.; SAGE Working Group on Vaccine Hesitancy: Measuring vaccine hesitancy: The development of a survey tool. Vaccine 33: 4165–4175, 2015 25896384
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabi K, et al.: A global survey of potential acceptance of a COVID-19 vaccine [published correction appears in Nat Med 27: 354, 2021 10.1038/s41591-020-01226-0]. Nat Med 27: 225–228, 2021
Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, et al.: National trends in the US public’s likelihood of getting a COVID-19 vaccine-April 1 to December 8, 2020. JAMA 325: 396–398, 2020
Hamel L, Kirzinger A, Muñana C, Brodie M: KFF COVID-19 vaccine monitor: December 2020, 2020. Available at: https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/ . Accessed December 15, 2020
Rumbaut RG, Massey DS: Immigration and language diversity in the United States. Daedalus 142: 141–154, 2013 25018562
van Buuren S, Boshuizen HC, Knook DL: Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18: 681–694, 1999 10204197
Van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, Rubin DB: Fully conditional specification in multivariate imputation. J Stat Comput Simul 76: 1049–1064, 2006
Little RJ, Rubin DB: Statistical Analysis with Missing Data, Vol. 793, Hoboken, New Jersey, John Wiley & Sons, 2019
Centers for Medicare and Medicaid Services: Dialysis facility report, 2020. Available at: https://data.cms.gov/dialysis-facility-reports . Accessed February 20, 2021
Hussein WF, Bennett PN, Pace S, Chen S, Legg V, Atwal J, et al.: The mobile health readiness of people receiving in-center hemodialysis and home dialysis. Clin J Am Soc Nephrol 16: 98–106, 2020 33355235

Auteurs

Pablo Garcia (P)

Department of Medicine (Nephrology), Stanford University, Stanford, California.

Maria E Montez-Rath (ME)

Department of Medicine (Nephrology), Stanford University, Stanford, California.

Heather Moore (H)

Office of the Chief Medical Officer, US Renal Care, Plano, Texas.

Johnie Flotte (J)

Office of the Chief Medical Officer, US Renal Care, Plano, Texas.

Chris Fults (C)

Office of the Chief Medical Officer, US Renal Care, Plano, Texas.

Martha S Block (MS)

Office of the Chief Medical Officer, US Renal Care, Plano, Texas.

Jialin Han (J)

Department of Medicine (Nephrology), Stanford University, Stanford, California.

Mary Dittrich (M)

Office of the Chief Medical Officer, US Renal Care, Plano, Texas.

Julie Parsonnet (J)

Departments of Medicine (Infectious Diseases and Geographic Medicine), and Epidemiology and Population Health, Stanford University, Stanford, California.

Glenn M Chertow (GM)

Departments of Medicine (Nephrology), and Epidemiology and Population Health, Stanford University, Stanford, California.

Geoffrey A Block (GA)

Office of the Chief Medical Officer, US Renal Care, Plano, Texas.

Shuchi Anand (S)

Department of Medicine (Nephrology), Stanford University, Stanford, California.

Classifications MeSH